Author:
Amin Hawraz Ibrahim M.,Maioli Chiara,Chianese Giuseppina,Appendino Giovanni,Gaeta Simone,Taglialatela-Scafati Orazio
Subject
Drug Discovery,Pharmacology,General Medicine
Reference15 articles.
1. on October 16;Accessed,2020
2. Effect of intravenous infusions of 12-O-tetradecanoylphorbol-13-acetate (TPA) in patients with myelocytic leukemia: Preliminary studies on therapeutic efficacy and toxicity;Han;Proc. Natl. Acad. Sci. U. S. A.,1998
3. B. Fang B, Y. Song, Z. Han, X. Wei, Q. Lin, X. Zhu, R. Yang, J. Sun, G. Tian, X. Liu, G. Cao, Y. Shi, N. Nie, D. Li, R. C. A. Zhao, Synergistic interactions between 12-O-tetradecanoylphorbol-13-acetate (TPA) and imatinib in patients with chronic myeloid leukemia in blastic phase that is resistant to standard-dose imatinib, Leuk. Res. 31 (2007) 1441–1447.
4. Phase I dose-escalation study to determine the safety, tolerability, preliminary efficacy and pharmacokinetics of an intratumoral injection of tigilanol tiglate (EBC-46);Panizza;EBioMedicine,2019
5. Randomized controlled clinical study evaluating the efficacy and safety of intratumoral treatment of canine mast cell tumors with tigilanol tiglate (EBC-46);De Ridder;J. Vet. Intern. Med.,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献